Leflunomide is also known as an anti-inflammatory drug used against rheumatoid arthritis, which increases mitochondrial elongation by depleting the pyrimidine pool and altering MFN1/2 protein levels through loss of pyrimidine synthesis (19, 29). This evidence concerns the gene MFN1 and rheumatoid arthritis.